"10.1371_journal.pone.0076154","plos one","2013-09-30T00:00:00Z","Jost B Jonas; Vinay Nangia; Anshu Khare; Maithili Kulkarni; Arshia Matin; Ajit Sinha; Krishna Bhojwani; Prabhat Nangia; Songhomitra Panda-Jonas","Suraj Eye Institute, Nagpur, India; Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls-University, Heidelberg, Mannheim, Germany","Conceived and designed the experiments: JBJ VN SPJ. Performed the experiments: JBJ VN AK MK AM AS KB PN SPJ. Analyzed the data: JBJ VN. Contributed reagents/materials/analysis tools: JBJ VN. Wrote the manuscript: JBJ VN SPJ.","This study was partly supported by the Heidelberg Engineering Co., and Carl Zeiss Meditec Co.  JBJ Consultant for Allergan Inc.; MSD; Alimera Co.; Patent holder with CellMed AG, Alzenau, Germany, Patent application number: 20120263794; Patent application title: TREATMENT OF EYE DISEASES USING ENCAPSULATED CELLS ENCODING AND SECRETING A NEUROPROTECTIVE FACTOR AND/OR AN ANTI-ANGIOGENIC FACTOR.  There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","09","Jost B Jonas","JBJ",9,TRUE,3,9,2,3,TRUE,TRUE,FALSE,0,NA,FALSE
